#Osaka #Health Tracker #Glico #Viome

Glico Launches the mRNA HEALTH TRACKER Service

In a pioneering move towards personalized health solutions, Glico Company has partnered with the U.S.-based health tech firm Viome Life Sciences to introduce a first-of-its-kind service in Japan called the "mRNA HEALTH TRACKER." This innovative service was officially launched on September 14, 2023, and aims to enhance individual health understanding through comprehensive gut microbiome analysis.

Understanding Gut Health

The mRNA HEALTH TRACKER utilizes cutting-edge mRNA testing technology to visualize the activity state of gut microbiota. By analyzing how gut bacteria are functioning, the service provides users with personalized health data that includes 26 different health scores based on their gut activity. Users will receive customized dietary recommendations from a selection of over 300 food items, helping them make informed choices for their health.

Personalized Guidance for Improved Health

The service not only offers a detailed analysis of gut activity but also links these findings to specific dietary options. Users can expect personalized food suggestions as well as recommendations for supplements and meal sets that align with their health scores. Additionally, experienced personal advisors are available to support users in modifying their eating habits and daily routines in accordance with their gut health insights.

Glico aims to foster a society where everyone understands their gut health and can continuously select the right foods for their bodies. With this initiative, Glico hopes to create significant health value for its users and contribute to better daily living and overall enhanced quality of life.

A Commitment to Holistic Health

With increasing awareness of health and disease prevention, the demand for tailored health and nutrition services is rapidly growing. Glico recognizes this trend and is committed to empowering individuals to practice "Precision Gut Care." The philosophy behind this service mirrors Glico founder Toshiichi Ezaki's vision of improving the public's health through food, a principle that has remained integral since the company's inception in 1922.

By integrating Glico's extensive knowledge in nutrition science and gut environment research with Viome’s advanced mRNA analysis technology, the mRNA HEALTH TRACKER aims to support users from the analysis of their gut activity through to food selection and lifestyle changes, all tailored to individual needs.

Comprehensive Service Overview

The mRNA HEALTH TRACKER is designed to analyze gut microbiota through mRNA testing, providing personalized health scores and corresponding food recommendations. Users simply collect a stool sample using a provided kit and complete a health questionnaire which informs their analysis. The results can be accessed via a web application, along with guidance from personal advisors who specialize in microbiology and nutrition.

Viome's Role in the Initiative

Viome is recognized for its groundbreaking approach to suggesting personalized dietary options based on gut microbiota analysis. By leveraging mRNA testing, the company provides insights into the optimal foods and habits suited to individual microbiomes. Through this partnership, Glico envisions combining their expertise in food and nutrition with Viome's innovative technology to pave the path for a new culinary science that resonates with individual health needs.

Conclusion

The mRNA HEALTH TRACKER initiative signifies Glico's commitment to scientific proof-based public health improvements. By equipping individuals with the necessary insights into their gut health and dietary preferences, Glico & Viome are paving the way for sustainable health management practices that can lead to longer, healthier lives. As Glico continues to evolve in line with health trends, they strive to contribute to a society where every individual can harness the power of their gut flora for a